The odds ratio for a positive disease-specific test result is 33.5 (95% CI 8.2-136.8, p<0.00001), when positive MRZ reaction is compared to MOG seropositivity and all true MS and MOGAD patients are included for testing. Here, MOG is linked to myeloid sarcoma.